Carregant...

An EMT-Related Gene Signature for Predicting Response to Adjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma

BACKGROUND: For pancreatic ductal adenocarcinoma (PDAC) patients, chemotherapy failure is the major reason for postoperative recurrence and poor outcomes. Establishment of novel biomarkers and models for predicting chemotherapeutic efficacy may provide survival benefits by tailoring treatments. METH...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Cell Dev Biol
Autors principals: Feng, Zengyu, Li, Kexian, Lou, Jianyao, Wu, Yulian, Peng, Chenghong
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8119901/
https://ncbi.nlm.nih.gov/pubmed/33996821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2021.665161
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!